New Age Alpha Advisors LLC Purchases 31,052 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

New Age Alpha Advisors LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 147,866.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 31,073 shares of the healthcare conglomerate’s stock after acquiring an additional 31,052 shares during the period. UnitedHealth Group accounts for about 0.6% of New Age Alpha Advisors LLC’s investment portfolio, making the stock its 22nd largest position. New Age Alpha Advisors LLC’s holdings in UnitedHealth Group were worth $15,719,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth approximately $40,000. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Piper Sandler decreased their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Finally, Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Buy” and an average price target of $629.32.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

Shares of UNH opened at $515.89 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The business has a 50-day simple moving average of $508.70 and a two-hundred day simple moving average of $545.16. The stock has a market cap of $471.89 billion, a price-to-earnings ratio of 33.28, a PEG ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company posted $5.83 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.